These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1352214)

  • 1. Metabolism of sodium nifurstyrenate, a veterinary antimicrobial nitrofuran, in animals and fish.
    Tatsumi K; Kitamura S; Kato M; Hiraoka K
    Drug Metab Dispos; 1992; 20(2):226-33. PubMed ID: 1352214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    Sugihara K; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro.
    Abraham RT; Knapp JE; Minnigh MB; Wong LK; Zemaitis MA; Alvin JD
    Drug Metab Dispos; 1984; 12(6):732-41. PubMed ID: 6150823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta- to omega-hydroxylation of the esophageal carcinogen methyl-n-amylnitrosamine by the rat esophagus and related tissues.
    Mirvish SS; Wang MY; Smith JW; Deshpande AD; Makary MH; Issenberg P
    Cancer Res; 1985 Feb; 45(2):577-83. PubMed ID: 3967233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity studies of a carcinogenic nitrofuran and some analogues.
    Jung R; Le JY; Wengenmayer F; Wolf E; Kramer M
    Biomed Biochim Acta; 1985; 44(3):485-92. PubMed ID: 4004844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies of the metabolism of furazolidone by rat liver microsomes.
    Vroomen LH; van Ommen B; van Bladeren PJ
    Toxicol In Vitro; 1987; 1(2):97-104. PubMed ID: 20647073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species.
    Tatsumi K; Kitamura S; Amano H; Ueda K
    Cancer Res; 1989 Apr; 49(8):2059-64. PubMed ID: 2702648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique tertiary amine N-oxide reduction system composed of quinone reductase and heme in rat liver preparations.
    Kitamura S; Sugihara K; Tatsumi K
    Drug Metab Dispos; 1999 Jan; 27(1):92-7. PubMed ID: 9884315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroreductase activity of mammalian liver aldehyde oxidase.
    Wolpert MK; Althaus JR; Johns DG
    J Pharmacol Exp Ther; 1973 May; 185(2):202-13. PubMed ID: 4145043
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxy metabolites of methyl-n-amylnitrosamine produced by esophagus, stomach, liver, and other tissues of the neonatal to adult rat and hamster.
    Mirvish SS; Ji CA; Rosinsky S
    Cancer Res; 1988 Oct; 48(20):5663-8. PubMed ID: 3167824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo metabolites of S-(2-benzothiazolyl)-L-cysteine as markers of in vivo cysteine conjugate beta-lyase and thiol glucuronosyl transferase activities.
    Elfarra AA; Hwang IY
    Drug Metab Dispos; 1990; 18(6):917-22. PubMed ID: 1981537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity.
    Zenser TV; Mattammal MB; Palmier MO; Davis BB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):735-40. PubMed ID: 6895386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
    Dudley BF; Winston GW
    Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
    Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
    Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalysis of the covalent binding of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol.
    Yamazoe Y; Shimada M; Shinohara A; Saito K; Kamataki T; Kato R
    Cancer Res; 1985 Jun; 45(6):2495-500. PubMed ID: 3986789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AF-2 [2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide].
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():47-61. PubMed ID: 6579016
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genotoxic properties of 5-nitrofuran compounds].
    Szczypka M
    Rocz Panstw Zakl Hig; 1995; 46(4):389-95. PubMed ID: 8619121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity of diallylnitrosamine following intragastric administration to Syrian hamsters.
    Grandjean CJ; Althoff J; Pour PM
    J Natl Cancer Inst; 1985 May; 74(5):1043-6. PubMed ID: 3858573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.